Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Colorado at Denver and Health Sciences Center National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | University of Colorado at Denver and Health Sciences Center |
ClinicalTrials.gov Identifier: | NCT00786630 |
This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the behaviors associated with HIV and HCV risk among injection drug users (IDUs) and to improve client overall functioning. The overall goal of this project is to compare strengths-based case-management (CM) to an enhanced version of CM that uses case managers to facilitate a therapeutic alliance (CM/FTA) among out-of-treatment IDUs in Denver.
Condition | Intervention |
---|---|
Substance Abuse |
Behavioral: Strengths-based case management Behavioral: Case management plus facilitated treatment alliance |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study |
Official Title: | Intervention to Reduce Injection Drug Use |
Estimated Enrollment: | 726 |
Study Start Date: | November 2007 |
Estimated Study Completion Date: | February 2011 |
Estimated Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Case Management: Experimental |
Behavioral: Strengths-based case management
Clients will receive counseling and/or referrals for help with nine life domains (life skills, finances, leisure activities, relationships, living arrangements, occupation/education, health, mental health, recovery from substances, legal assistance) for a period of five months after baseline.
|
Facilitated Treatment Alliance: Experimental |
Behavioral: Case management plus facilitated treatment alliance
Clients will receive counseling and/or referrals for help with nine life domains (life skills, finances, leisure activities, relationships, living arrangements, occupation/education, health, mental health, recovery from substances, legal assistance) for a period of five months after baseline. They will also receive a facilitated treatment alliance, which consists of meetings with methadone counselors to aid in treatment entry.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Robert E. Booth, Ph.D. | 303-315-0960 | Robert.Booth@ucdenver.edu |
United States, Colorado | |
Project Safe | Recruiting |
Denver, Colorado, United States, 80205 | |
Contact: Mark Royer, MA 303-315-0987 Mark.Royer@ucdenver.edu |
Principal Investigator: | Robert E. Booth, Ph.D. | University of Colorado at Denver and Health Sciences Center |
Responsible Party: | University of Colorado Denver ( Robert Booth ) |
Study ID Numbers: | 06-1131, 2RO1 DA09832-11 |
Study First Received: | November 4, 2008 |
Last Updated: | November 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00786630 |
Health Authority: | United States: Institutional Review Board; United States: Federal Government |
Drug treatment entry and retention Drug injection frequency HIV risk behaviors Hepatitis C risk behaviors |
Hepatitis Methadone Mental Disorders HIV Infections Acquired Immunodeficiency Syndrome |
Substance-Related Disorders Disorders of Environmental Origin Hepatitis C Urinary Retention |